Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
C Wolf(Laboratoire de Microbiologie et Génétique Moléculaires), Paul Basset(Laboratoire de Microbiologie et Génétique Moléculaires), Jean‐Pierre Bellocq(Laboratoire de Microbiologie et Génétique Moléculaires), Yves Lutz(Laboratoire de Microbiologie et Génétique Moléculaires), N. Rouyer(Laboratoire de Microbiologie et Génétique Moléculaires), Pierre Chambon(Laboratoire de Microbiologie et Génétique Moléculaires), Colette Adida(Laboratoire de Microbiologie et Génétique Moléculaires), Marie‐Anne Loriot(Unknown)
Cited by 207
Related Papers
Influence of Human Immunodeficiency Virus Infection on Chronic Hepatitis B in Homosexual Men
|Hepatology|1999|445
Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing
|Clinical Pharmacology & Therapeutics|2010|363
Analgesic effect of acetaminophen in humans: First evidence of a central serotonergic mechanism
|Clinical Pharmacology & Therapeutics|2006|278
The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c‐Ha‐ras oncoprotein and the c‐jun protein.
|The EMBO Journal|1989|263
Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based Chemotherapy
|Clinical Cancer Research|2004|241